Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18–64 Years: A Randomized, Open-Label Trial

BACKGROUND: Antibody responses to non–egg-based standard-dose cell-culture influenza vaccine (containing 15 µg hemagglutinin [HA]/component) and recombinant vaccine (containing 45 µg HA/component) during consecutive seasons have not been studied in the United States. METHODS: In a randomized trial o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaglani, Manjusha, Kim, Sara S, Naleway, Allison L, Levine, Min Z, Edwards, Laura, Murthy, Kempapura, Dunnigan, Kayan, Zunie, Tnelda, Groom, Holly, Ball, Sarah, Jeddy, Zuha, Hunt, Danielle, Wesley, Meredith G, Sambhara, Suryaprakash, Gangappa, Shivaprakash, Grant, Lauren, Cao, Weiping, Gross, F Liaini, Mishina, Margarita, Fry, Alicia M, Thompson, Mark G, Dawood, Fatimah S, Flannery, Brendan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907492/
https://www.ncbi.nlm.nih.gov/pubmed/36031405
http://dx.doi.org/10.1093/cid/ciac683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907492/
https://www.ncbi.nlm.nih.gov/pubmed/36031405
http://dx.doi.org/10.1093/cid/ciac683

Ejemplares similares